glp-1 agonists drug class America's Poison Centers TrimRX | GLP-1 vs GIP:

Gastrointestinal side effects demonstrated higher incidence compared to GLP-1 monotherapy (nausea 66% vs

[DOI] [PMC free article] [PubMed] [Google Scholar] 231.Lu Y., Liu Y., Krumholz H.M

Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 Randomized Clinical Trial

I dont know the answer to the first part, but the second part seems unlikely

171 IR is still the key link between diabetes and PD and may impair nigrostriatal dopamine function, 172 exacerbate nigrostriatal DA depletion, 173 and enhance cognitive impairment 174 and behavioral abnormalities

Wegovy FDA Label